1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
624C1FCC867F6BD9F85256E3D006D3973
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/developing-global-trademarks-benchmarking-strategy-process?opendocument
18
19opendocument
203.235.120.150
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Sales and Marketing Marketing Management Deploying Marketing Programs Brand Management

Developing Global Trademarks: Benchmarking Strategy & Process

DB Image

ID: 4557


Features:

Metrics, Graphics


Published: Pre-2016


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Based on a survey and executive interviews with 13 market leaders, this 40-slide study identifies differences in strategies and processes used to develop global trademarks.

Key topic areas covered include:

I. STRATEGY
• Trends in Approaches to Global Trademark Development
• Global Versus Regional Versus Country-Specific
• Methods Used to Find Commercially Viable Trademarks and Generic Names
• Types of Trademarks Preferred
• Timing of Creation of Trademark and Generic Names
II. PROCESS
• Internal Versus External Provision of Work and Vendors Used
• Searching and Filing Techniques
• Intentions Towards Madrid Protocol
• Approaches to Use of Domain Names

Readers will be able to understand other companies' approaches to trademark development, identify trends in trademark strategies, view geographical differences in trademark processes and gain insight from top executives' lessons learned in trademark development.

This study originated with the Business Excellence Board.

Industries Profiled:
Medical Device; Pharmaceutical; Biotech; Research; Health Care


Companies Profiled:
3M Pharmaceuticals; Sanofi-aventis; Endo Pharmaceuticals; Genzyme; United Laboratories; Inc.; AstraZeneca; Schwarz Pharmaceuticals; Johnson & Johnson; Merck; Eli Lilly and Company; Navigant; Pfizer; Schering-Plough

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.